Health and medicine

Deal with US drug company raises controversy in Egypt over use of anti-coronavirus treatment

Egypt’s Eva Pharma reached a deal with Gilead Sciences to locally manufacture the antiviral treatment Remdesivir for the treatment of coronavirus patients and distribute it in 127 countries.

Amr Mostafa | Health and medicine | Jun 24, 2020
al-monitor Gilead Sciences, Inc., pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease, Oceanside, California, April 29, 2020. Photo by REUTERS/Mike Blake.

Egypt's lucrative blood plasma black market

Selling the plasma of COVID-19 survivors has become a profitable illegal business, after the minister of health announced that using survivor plasma to treat coronavirus patients has proven effective.

A correspondent in Egypt | Health and medicine | Jun 19, 2020

Suicide rates increase within Iraq’s Yazidi community

The number of suicides among Iraqi Yazidis have been increasing recently, while they receive little support from local and international organizations in this regard.

Brenda Stoter | Health and medicine | May 15, 2020

Israel gives final go-ahead for cannabis exports

Israeli Economy Minister Eli Cohen gives his final approval for the export of medical cannabis.

Al-Monitor Staff | Health and medicine | May 13, 2020

Coronavirus reveals Palestinian economic dependence on Israel

The coronavirus crisis reveals the dependence of the Palestinian economy on its Israeli counterpart, especially with regard to workers and the sources of income of thousands of families in the West Bank and Gaza Strip.

Adnan Abu Amer | Health and medicine | Apr 24, 2020